A Comprehensive Review on Phage Therapy and Phage-Based Drug Development

Комплексный обзор фаговой терапии и разработки лекарственных средств на основе фагов
Longzhu Cui, Shinya Watanabe, Kazuhiko Miyanaga, Kotaro Kiga, Teppei Sasahara, Yoshifumi Aiba, Xin-Ee Tan, Srivani Veeranarayanan, Kanate Thitiananpakorn, Huong Minh Nguyen, Dhammika Leshan Wannigama
2024-09-11

bacteriophage-based drug developmentbiofilm-associated infectionsgene delivery vectorsmultidrug-resistant bacteriaphage therapy
Phage therapy, the use of bacteriophages (phages) to treat bacterial infections, is regaining momentum as a promising weapon against the rising threat of multidrug-resistant (MDR) bacteria. This comprehensive review explores the historical context, the modern resurgence of phage therapy, and phage-facilitated advancements in medical and technological fields. It details the mechanisms of action and applications of phages in treating MDR bacterial infections, particularly those associated with biofilms and intracellular pathogens. The review further highlights innovative uses of phages in vaccine development, cancer therapy, and as gene delivery vectors. Despite its targeted and efficient approach, phage therapy faces challenges related to phage stability, immune response, and regulatory approval. By examining these areas in detail, this review underscores the immense potential and remaining hurdles in integrating phage-based therapies into modern medical practices.
1
Major barriers to clinical integration include phage stability, host immune responses, and regulatory approval requirements.
2
Phage therapy is regaining prominence as a potential treatment strategy against multidrug-resistant bacterial infections.
3
Phage-based technologies have applications beyond infection treatment, including vaccine development, cancer therapy, and gene delivery.
4
Phages can target challenging infections involving bacterial biofilms and intracellular pathogens through specific antibacterial mechanisms.
5
The review concludes that phage-based therapies have substantial medical potential but require solutions to stability, immunological, and regulatory challenges.

phage therapy and phage-based drug development for treating multidrug-resistant bacterial infections

mechanisms, medical applications, therapeutic potential, and challenges of phage-based interventions, including treatment of biofilm-associated and intracellular infections

Publication Details
Publication Date
2024-09-11
Journal
Publisher
ISSN
Cited by
131
Access Type
Author Information
Authors
Longzhu Cui
Shinya Watanabe
Kazuhiko Miyanaga
Kotaro Kiga
Teppei Sasahara
Yoshifumi Aiba
Xin-Ee Tan
Srivani Veeranarayanan
Kanate Thitiananpakorn
Huong Minh Nguyen
Dhammika Leshan Wannigama
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%